Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Effect of 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carbamoyl]Benzoic Acid (Am80) on Alveolar Regeneration in Adiponectin Deficient-Mice Showing a Chronic Obstructive Pulmonary Disease–Like Pathophysiology
Hitomi Sakai, Michiko Horiguchi, Tomomi Akita, Chihiro Ozawa, Mai Hirokawa, Yuki Oiso, Harumi Kumagai, Yoshito Takeda, Isao Tachibana, Norikazu Maeda and Chikamasa Yamashita
Journal of Pharmacology and Experimental Therapeutics June 2017, 361 (3) 501-505; DOI: https://doi.org/10.1124/jpet.117.240515
Hitomi Sakai
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Michiko Horiguchi
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Tomomi Akita
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Chihiro Ozawa
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Mai Hirokawa
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Yuki Oiso
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Harumi Kumagai
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Yoshito Takeda
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Isao Tachibana
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Norikazu Maeda
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
Chikamasa Yamashita
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences (H.S., M.Ho., T.A., C.O., M.Hi., O.Y., H.K., C.Y.), and Fusion of Regenerative Medicine with DDS, Research Institute for Science and Technology (M.Ho., C.Y.), Tokyo University of Science, Chiba; Respiratory Medicine, Allergy and Rheumatic Diseases (Y.T., I.T., N.M.), and Department of Metabolism and Atherosclerosis (N.M.), Graduate School of Medicine, Osaka University, Osaka; Department of Medicine, Nissay Hospital, Nippon Life Saiseikai Public Interest Incorporated Foundation, Osaka (I.T.), Japan
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Alveolar Regeneration in COPD-like Pathophysiology of Mice
Hitomi Sakai, Michiko Horiguchi, Tomomi Akita, Chihiro Ozawa, Mai Hirokawa, Yuki Oiso, Harumi Kumagai, Yoshito Takeda, Isao Tachibana, Norikazu Maeda and Chikamasa Yamashita
Journal of Pharmacology and Experimental Therapeutics June 1, 2017, 361 (3) 501-505; DOI: https://doi.org/10.1124/jpet.117.240515
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Alveolar Regeneration in COPD-like Pathophysiology of Mice
Hitomi Sakai, Michiko Horiguchi, Tomomi Akita, Chihiro Ozawa, Mai Hirokawa, Yuki Oiso, Harumi Kumagai, Yoshito Takeda, Isao Tachibana, Norikazu Maeda and Chikamasa Yamashita
Journal of Pharmacology and Experimental Therapeutics June 1, 2017, 361 (3) 501-505; DOI: https://doi.org/10.1124/jpet.117.240515
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement